Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Contributor

BioCryst Hit 15-Year Highs But What's In Store Tomorrow For Earnings?

By StoryTrading

BioCryst’s (NASDAQ:BCRX) stock price hit 15-year highs since our article was published on Benzinga earlier this month, but with the oral prophylactic treatment provider’s 2021 financial results due out this Wednesday, some traders may be wondering whether it’s time to take some money off the table.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.